Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome is a multiple congenital anomalies syndrome, reported in the offsprings of a consanguineous couple and characterized by multiple congenital skeletal (dolichocephaly, skull asymmetry, camptodactyly, clubfoot), muscular (muscle hypoplasia), ocular (anophthalmia, buphthalmos, retinal detachment, aniridia) and cardiac (prolapse of tricuspid valves, mitral and tricuspid insufficiency) abnormalities. An autosomal recessive inheritance with variable expressivity was suspected. There have been no further descriptions in the literature since 1992.
Biomarker and diagnostic research for anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome.
201 publications have been identified in PubMed for anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome. Kisho has analyzed 84 by research type. Research spans Review / Meta-Analysis (61%), Basic Science / Preclinical (17%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 51 | 61% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 14 | 17% |
Patient case studies | 11 | 13% |
Testing and diagnosis research | 4 | 5% |
Clinical study results | 2 | 2% |
Disease patterns and progression | 2 | 2% |
Richert Q (2026). [PMID: 41619932](https://pubmed.ncbi.nlm.nih.gov/41619932/). *Chest*. [Review / Meta-Analysis]
van der Leij M (2026). [PMID: 41680088](https://pubmed.ncbi.nlm.nih.gov/41680088/). *Am J Med Genet A*. [Clinical Trial Publication]
Chopra A (2026). [PMID: 41870099](https://pubmed.ncbi.nlm.nih.gov/41870099/). *Int Ophthalmol Clin*. [Review / Meta-Analysis]
Shin BK (2025). [PMID: 40089178](https://pubmed.ncbi.nlm.nih.gov/40089178/). *Eur J Med Genet*. [Case Report / Case Series]
Martin B (2025). [PMID: 40963452](https://pubmed.ncbi.nlm.nih.gov/40963452/). *Pediatr Dermatol*. [Review / Meta-Analysis]
Mutai H (2025). [PMID: 39755840](https://pubmed.ncbi.nlm.nih.gov/39755840/). *Hum Genet*. [Basic Science / Preclinical]
Silvey S (2025). [PMID: 41010008](https://pubmed.ncbi.nlm.nih.gov/41010008/). *Genes (Basel)*. [Case Report / Case Series]
Löbel U (2025). [PMID: 39393841](https://pubmed.ncbi.nlm.nih.gov/39393841/). *AJNR Am J Neuroradiol*. [Diagnostic / Biomarker]
Motta AB (2025). [PMID: 38549535](https://pubmed.ncbi.nlm.nih.gov/38549535/). *Curr Med Chem*. [Review / Meta-Analysis]
Biglari S (2025). [PMID: 40101970](https://pubmed.ncbi.nlm.nih.gov/40101970/). *J Med Genet*. [Basic Science / Preclinical]
AI-curated news mentioning anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome
Updated Jul 29, 2026
Recent research published in PubMed explores the relationship between Graves' orbitopathy and anophthalmia, shedding light on potential underlying mechanisms. This study may provide insights for future therapeutic strategies in managing these conditions.
A study analyzed 111 patients with bilateral anterior segment dysgenesis, aniridia, microphthalmia, and anophthalmia, providing insights into the molecular and clinical characteristics of these conditions. The findings may enhance understanding and management of these rare eye disorders.